Europe Molecular Diagnostics Market (Product: Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems) - Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2024-2034

Europe Molecular Diagnostics Market (Product: Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems) - Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2024-2034


Europe Molecular Diagnostics Market – Scope of Report

TMR’s report on the Europe molecular diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the Europe molecular diagnostics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the Europe molecular diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the molecular diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the Europe molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the Europe molecular diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the Europe molecular diagnostics market.

The report delves into the competitive landscape of the Europe molecular diagnostics market. Key players operating in the Europe molecular diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the Europe molecular diagnostics market profiled in this report.

Key Questions Answered in Europe molecular diagnostics Market Report
  • What is the sales/revenue generated by molecular diagnostics across all regions during the forecast period?
  • What are the opportunities in the Europe molecular diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue Europely in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the Europe market?
Europe Molecular Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the Europe molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the Europe molecular diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the Europe molecular diagnostics market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Europe Molecular Diagnostics Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution/Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. Europe Molecular Diagnostics Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product/Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Europe Molecular Diagnostics Market Analysis and Forecast, by Product
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Product, 2020-2034
  6.3.1. Real-time PCR Systems
  6.3.1.1. LightCycler 480
  6.3.1.2. PCRmax Eco 48
  6.3.1.3. Applied Biosystems 7900HT
  6.3.1.4. QuantStudio Real-Time PCR
  6.3.1.5. ViiA 7 Real-Time PCR
  6.3.1.6. C1000 Touch
  6.3.1.7. ABI StepOnePlus Real-Time PCR
  6.3.1.8. 5ABI 7500
  6.3.1.9. AriaMx Real-time PCR System
  6.3.1.10. CFX Connect
  6.3.1.11. CFX384 Touch
  6.3.1.12. MiniOpticon
  6.3.1.13. Others
  6.3.2. Liquid Handling Systems
  6.3.2.1. epMotion
  6.3.2.2. Biomek
  6.3.2.3. Freedom EVO
  6.3.2.4. Tecan D300e Digital Dispenser
  6.3.2.5. Precision
  6.3.2.6. JANUS
  6.3.2.7. Others
  6.3.3. DNA Extraction Systems
  6.3.3.1. AutoMate Express
  6.3.3.2. QIAcube
  6.3.3.3. InnuPure
  6.3.3.4. VERSA
  6.3.3.5. Chemagic
  6.3.3.6. Others
  6.4. Market Attractiveness Analysis, by Product
7. Europe Molecular Diagnostics Market Analysis and Forecast, by End-user
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by End-user, 2020-2034
  7.3.1. Hospitals
  7.3.2. Diagnostics Laboratories
  7.3.3. Academic & Research Institutes
  7.3.4. Pharmaceutical & Biotechnology Companies
  7.4. Market Attractiveness Analysis, by End-user
8. Europe Molecular Diagnostics Market Analysis and Forecast, by Country
  8.1. Key Findings
  8.2. Market Value Forecast, by Country, 2020-2034
  8.2.1. Italy
  8.2.2. Europe
  8.2.3. U.K.
  8.2.4. France
  8.2.5. Germany
  8.3. Market Attractiveness Analysis, by Country
9. Italy Molecular Diagnostics Market Analysis and Forecast
  9.1. Introduction
  9.2. Key Findings
  9.3. Market Value Forecast, by Product, 2020-2034
  9.3.1. Real-time PCR Systems
  9.3.1.1. LightCycler 480
  9.3.1.2. PCRmax Eco 48
  9.3.1.3. Applied Biosystems 7900HT
  9.3.1.4. QuantStudio Real-Time PCR
  9.3.1.5. ViiA 7 Real-Time PCR
  9.3.1.6. C1000 Touch
  9.3.1.7. ABI StepOnePlus Real-Time PCR
  9.3.1.8. 5ABI 7500
  9.3.1.9. AriaMx Real-time PCR System
  9.3.1.10. CFX Connect
  9.3.1.11. CFX384 Touch
  9.3.1.12. MiniOpticon
  9.3.1.13. Others
  9.3.2. Liquid Handling Systems
  9.3.2.1. epMotion
  9.3.2.2. Biomek
  9.3.2.3. Freedom EVO
  9.3.2.4. Tecan D300e Digital Dispenser
  9.3.2.5. Precision
  9.3.2.6. JANUS
  9.3.2.7. Others
  9.3.3. DNA Extraction Systems
  9.3.3.1. AutoMate Express
  9.3.3.2. QIAcube
  9.3.3.3. InnuPure
  9.3.3.4. VERSA
  9.3.3.5. Chemagic
  9.3.3.6. Others
  9.4. Market Value Forecast, by End-user, 2020-2034
  9.4.1. Hospitals
  9.4.2. Diagnostics Laboratories
  9.4.3. Academic & Research Institutes
  9.4.4. Pharmaceutical & Biotechnology Companies
  9.5. Market Value Forecast, by Country, 2020-2034
  9.5.1. U.S.
  9.5.2. Canada
  9.6. Market Attractiveness Analysis
  9.6.1. By Product
  9.6.2. By End-user
10. Spain Molecular Diagnostics Market Analysis and Forecast
  10.1. Introduction
  10.2. Key Findings
  10.3. Market Value Forecast, by Product, 2020-2034
  10.3.1. Real-time PCR Systems
  10.3.1.1. LightCycler 480
  10.3.1.2. PCRmax Eco 48
  10.3.1.3. Applied Biosystems 7900HT
  10.3.1.4. QuantStudio Real-Time PCR
  10.3.1.5. ViiA 7 Real-Time PCR
  10.3.1.6. C1000 Touch
  10.3.1.7. ABI StepOnePlus Real-Time PCR
  10.3.1.8. 5ABI 7500
  10.3.1.9. AriaMx Real-time PCR System
  10.3.1.10. CFX Connect
  10.3.1.11. CFX384 Touch
  10.3.1.12. MiniOpticon
  10.3.1.13. Others
  10.3.2. Liquid Handling Systems
  10.3.2.1. epMotion
  10.3.2.2. Biomek
  10.3.2.3. Freedom EVO
  10.3.2.4. Tecan D300e Digital Dispenser
  10.3.2.5. Precision
  10.3.2.6. JANUS
  10.3.2.7. Others
  10.3.3. DNA Extraction Systems
  10.3.3.1. AutoMate Express
  10.3.3.2. QIAcube
  10.3.3.3. InnuPure
  10.3.3.4. VERSA
  10.3.3.5. Chemagic
  10.3.3.6. Others
  10.4. Market Value Forecast, by End-user, 2020-2034
  10.4.1. Hospitals
  10.4.2. Diagnostics Laboratories
  10.4.3. Academic & Research Institutes
  10.4.4. Pharmaceutical & Biotechnology Companies
  10.5. Market Attractiveness Analysis
  10.5.1. By Product
  10.5.2. By End-user
11. U.K. Molecular Diagnostics Market Analysis and Forecast
  11.1. Introduction
  11.2. Key Findings
  11.3. Market Value Forecast, by Product, 2020-2034
  11.3.1. Real-time PCR Systems
  11.3.1.1. LightCycler 480
  11.3.1.2. PCRmax Eco 48
  11.3.1.3. Applied Biosystems 7900HT
  11.3.1.4. QuantStudio Real-Time PCR
  11.3.1.5. ViiA 7 Real-Time PCR
  11.3.1.6. C1000 Touch
  11.3.1.7. ABI StepOnePlus Real-Time PCR
  11.3.1.8. 5ABI 7500
  11.3.1.9. AriaMx Real-time PCR System
  11.3.1.10. CFX Connect
  11.3.1.11. CFX384 Touch
  11.3.1.12. MiniOpticon
  11.3.1.13. Others
  11.3.2. Liquid Handling Systems
  11.3.2.1. epMotion
  11.3.2.2. Biomek
  11.3.2.3. Freedom EVO
  11.3.2.4. Tecan D300e Digital Dispenser
  11.3.2.5. Precision
  11.3.2.6. JANUS
  11.3.2.7. Others
  11.3.3. DNA Extraction Systems
  11.3.3.1. AutoMate Express
  11.3.3.2. QIAcube
  11.3.3.3. InnuPure
  11.3.3.4. VERSA
  11.3.3.5. Chemagic
  11.3.3.6. Others
  11.4. Market Value Forecast, by End-user, 2020-2034
  11.4.1. Hospitals
  11.4.2. Diagnostics Laboratories
  11.4.3. Academic & Research Institutes
  11.4.4. Pharmaceutical & Biotechnology Companies
  11.5. Market Attractiveness Analysis
  11.5.1. By Product
  11.5.2. By End-user
12. France Molecular Diagnostics Market Analysis and Forecast
  12.1. Introduction
  12.2. Key Findings
  12.3. Market Value Forecast, by Product, 2020-2034
  12.3.1. Real-time PCR Systems
  12.3.1.1. LightCycler 480
  12.3.1.2. PCRmax Eco 48
  12.3.1.3. Applied Biosystems 7900HT
  12.3.1.4. QuantStudio Real-Time PCR
  12.3.1.5. ViiA 7 Real-Time PCR
  12.3.1.6. C1000 Touch
  12.3.1.7. ABI StepOnePlus Real-Time PCR
  12.3.1.8. 5ABI 7500
  12.3.1.9. AriaMx Real-time PCR System
  12.3.1.10. CFX Connect
  12.3.1.11. CFX384 Touch
  12.3.1.12. MiniOpticon
  12.3.1.13. Others
  12.3.2. Liquid Handling Systems
  12.3.2.1. epMotion
  12.3.2.2. Biomek
  12.3.2.3. Freedom EVO
  12.3.2.4. Tecan D300e Digital Dispenser
  12.3.2.5. Precision
  12.3.2.6. JANUS
  12.3.2.7. Others
  12.3.3. DNA Extraction Systems
  12.3.3.1. AutoMate Express
  12.3.3.2. QIAcube
  12.3.3.3. InnuPure
  12.3.3.4. VERSA
  12.3.3.5. Chemagic
  12.3.3.6. Others
  12.4. Market Value Forecast, by End-user, 2020-2034
  12.4.1. Hospitals
  12.4.2. Diagnostics Laboratories
  12.4.3. Academic & Research Institutes
  12.4.4. Pharmaceutical & Biotechnology Companies
  12.5. Market Attractiveness Analysis
  12.5.1. By Product
  12.5.2. By End-user
13. Germany Molecular Diagnostics Market Analysis and Forecast
  13.1. Introduction
  13.2. Key Findings
  13.3. Market Value Forecast, by Product, 2020-2034
  13.3.1. Real-time PCR Systems
  13.3.1.1. LightCycler 480
  13.3.1.2. PCRmax Eco 48
  13.3.1.3. Applied Biosystems 7900HT
  13.3.1.4. QuantStudio Real-Time PCR
  13.3.1.5. ViiA 7 Real-Time PCR
  13.3.1.6. C1000 Touch
  13.3.1.7. ABI StepOnePlus Real-Time PCR
  13.3.1.8. 5ABI 7500
  13.3.1.9. AriaMx Real-time PCR System
  13.3.1.10. CFX Connect
  13.3.1.11. CFX384 Touch
  13.3.1.12. MiniOpticon
  13.3.1.13. Others
  13.3.2. Liquid Handling Systems
  13.3.2.1. epMotion
  13.3.2.2. Biomek
  13.3.2.3. Freedom EVO
  13.3.2.4. Tecan D300e Digital Dispenser
  13.3.2.5. Precision
  13.3.2.6. JANUS
  13.3.2.7. Others
  13.3.3. DNA Extraction Systems
  13.3.3.1. AutoMate Express
  13.3.3.2. QIAcube
  13.3.3.3. InnuPure
  13.3.3.4. VERSA
  13.3.3.5. Chemagic
  13.3.3.6. Others
  13.4. Market Value Forecast, by End-user, 2020-2034
  13.4.1. Hospitals
  13.4.2. Diagnostics Laboratories
  13.4.3. Academic & Research Institutes
  13.4.4. Pharmaceutical & Biotechnology Companies
  13.5. Market Attractiveness Analysis
  13.5.1. By Product
  13.5.2. By End-user
14. Competition Landscape
  14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  14.2. Market Share Analysis, by Company (2023)
  14.3. Company Profiles
  14.3.1. Agilent Technologies, Inc.
  14.3.1.1. Company Overview
  14.3.1.2. Product Portfolio
  14.3.1.3. SWOT Analysis
  14.3.1.4. Financial Overview
  14.3.1.5. Strategic Overview
  14.3.2. BD
  14.3.2.1. Company Overview
  14.3.2.2. Product Portfolio
  14.3.2.3. SWOT Analysis
  14.3.2.4. Financial Overview
  14.3.2.5. Strategic Overview
  14.3.3. Bio-Rad Laboratories, Inc.
  14.3.3.1. Company Overview
  14.3.3.2. Product Portfolio
  14.3.3.3. SWOT Analysis
  14.3.3.4. Financial Overview
  14.3.3.5. Strategic Overview
  14.3.4. Danaher
  14.3.4.1. Company Overview
  14.3.4.2. Product Portfolio
  14.3.4.3. SWOT Analysis
  14.3.4.4. Financial Overview
  14.3.4.5. Strategic Overview
  14.3.5. Eppendorf SE
  14.3.5.1. Company Overview
  14.3.5.2. Product Portfolio
  14.3.5.3. SWOT Analysis
  14.3.5.4. Financial Overview
  14.3.5.5. Strategic Overview
  14.3.6. F. Hoffmann-La Roche Ltd.
  14.3.6.1. Company Overview
  14.3.6.2. Product Portfolio
  14.3.6.3. SWOT Analysis
  14.3.6.4. Financial Overview
  14.3.6.5. Strategic Overview
  14.3.7. PerkinElmer, Inc.
  14.3.7.1. Company Overview
  14.3.7.2. Product Portfolio
  14.3.7.3. SWOT Analysis
  14.3.7.4. Financial Overview
  14.3.7.5. Strategic Overview
  14.3.8. Tecan Trading AG
  14.3.8.1. Company Overview
  14.3.8.2. Product Portfolio
  14.3.8.3. SWOT Analysis
  14.3.8.4. Financial Overview
  14.3.8.5. Strategic Overview
  14.3.9. Thermo Fisher Scientific, Inc.
  14.3.9.1. Company Overview
  14.3.9.2. Product Portfolio
  14.3.9.3. SWOT Analysis
  14.3.9.4. Financial Overview
  14.3.9.5. Strategic Overview
  14.3.10. QIAGEN
  14.3.10.1. Company Overview
  14.3.10.2. Product Portfolio
  14.3.10.3. SWOT Analysis
  14.3.10.4. Financial Overview
  14.3.10.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings